Investor Center » Investor Contact

 
Helle Husted, M.A. 
Vice President, Investor Relations 
Address 
Bredgade 34 
1260 Copenhagen K 
Denmark 

Telephone + 45 7020 2728 
Fax + 45 7020 2729
Send email 


Investor Relations and Public Relations 

Purpose
Genmab is committed to carrying out effective communication with the financial community and has therefore established a dedicated department for Investor and Public Relations.

Policy
Genmab is listed on the NASDAQ OMX Copenhagen A/S. In accordance with disclosure regulations all important stock price relevant information is released first to the OMX via a stock exchange notice in the form of a press release. Information about the company which is not price relevant but could still be of interest is communicated through an investor news release. Once company news is published at the OMX we distribute the release to our own mailing lists of investors, analysts, journalists and other contacts across the world.

Genmab explores different ways to communicate information already released through the OMX including webcasts, telephone conferences, the Internet and investor meetings.

In the interest of good corporate governance Genmab pursues a policy of not holding investor meetings in the immediate run up to the release of interim or full year financial reports.

Website
Genmab is committed to making ongoing improvements to the information we provide on our website. All press releases and financial documents are posted on the company’s website along with a description of the warrants program and our product pipeline and partnerships pages are regularly updated. We also provide stock information, investor relations contact information, a list of the analysts covering Genmab, the company’s financial calendar and a list of conferences and other events Genmab is involved in.

Financial Reporting
Genmab is committed to a high standard of financial reporting. The company lives up to the requirements of the NASDAQ OMX Copenhagen A/S by providing quarterly financial reports. All published financial reports are available on our website.